Metabiomics
  • Home
  • LifeKit® Prevent
  • Technology
    • Microbiome Health
    • Microbiome Research News
    • Publications
  • About Us
    • Press Releases
    • Management
    • Careers
  • Contact Us
Select Page
MultiTag™ Sequencing Patent Award in US Clears Path for Metabiomics Colorectal Cancer and Gastrointestinal Disease Molecular Diagnostic Clinical Trials

MultiTag™ Sequencing Patent Award in US Clears Path for Metabiomics Colorectal Cancer and Gastrointestinal Disease Molecular Diagnostic Clinical Trials

by Greg Kuehn | Dec 10, 2013 | Research News

POTOMAC FALLS, VA, December 10, 2013 Metabiomics is pioneering the development of molecular diagnostic tests for colorectal cancer, inflammatory bowel disease, and other gastrointestinal cancers and autoimmune diseases built on an exclusive worldwide license from...
MultiTag Sequencing™ Services Now Available for Genomics Research Applications

MultiTag Sequencing™ Services Now Available for Genomics Research Applications

by Greg Kuehn | Apr 15, 2011 | Press Releases, Research News

Manassas, VA (April 15, 2009) — Metabiomics© is now offering the human Genomics research community advanced MultiTag Sequencing™ primers and services including a limited license to use its patent pending MultiTag Sequencing™ method for research purposes. This...
MultiTag Sequencing™ Patent Application Advances to National Phase

MultiTag Sequencing™ Patent Application Advances to National Phase

by Greg Kuehn | Jun 7, 2010 | Press Releases

Metabiomics© announced that it received a favorable International Preliminary Report on Patentability from the Patent Cooperation Treaty (PCT) on its application to patent its enabling MultiTag Sequencing™ (MTPS) method for unique identification of multiple samples...
Breakthrough MultiTag Sequencing™ Primers and Services Now Available for Metagenomics Research

Breakthrough MultiTag Sequencing™ Primers and Services Now Available for Metagenomics Research

by Greg Kuehn | Jun 7, 2010 | Press Releases, Research News

Advanced MultiTag Sequencing™ primer kits and full line of pyrosequencing services are now available from Metabiomics© to the Microbiome research community to increase throughput, productivity, and comparative statistical analysis, differentiating subject populations,...
New Microbiome Research Center Advances MultiTag Sequencing™ Technology

New Microbiome Research Center Advances MultiTag Sequencing™ Technology

by Greg Kuehn | Apr 15, 2009 | Press Releases, Research News

Manassas, VA (April 15, 2009) – The newly organized MicroBiome Analysis Center (MBAC) at George Mason University has partnered with Metabiomics to map the world that bacteria, viruses, fungi and protozoa inhabit the human body called the Human Microbiome. The MBAC has...

Recent News

  • Prescient Metabiomics and the Harvard Chan Microbiome in Public Health Center Collaborate to Advance Research in Colon Cancer Screening March 20, 2020
  • Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test December 17, 2019
  • FDA Grants Breakthrough Designation to the Prescient Metabiomics LifeKit® Prevent Test for the Early Detection of Colon Polyps and Colon Cancer September 5, 2019

Tag Cloud

Breakthrough Device China clinical studies colon cancer screening colon cancer test colon polyp Colorado Capital Conference colorectal adenoma colorectal cancer colorectal cancer diagnostics colorectal cancer screening CoreBiome Curtis Huttenhower Dan Knights Harvard Investor conference Keri Donaldson Kindstar LifeKit Prevent MB-01 MBAC Metabiomics Metagenomics Microbiome microbiome diagnostics microbiome sampling kit Mid-Atlantic Bio molecular diagnostics MultiTag Sequencing neoplasia Next-Generation Sequencing OCTANe Medical Device & Investor Forum Oricol Origin Sciences patents Patrick Gillevet Prescient Medicine Series A

RSS Feeds

  • RSS - Posts
  • RSS - Comments

Recent News

  • Prescient Metabiomics and the Harvard Chan Microbiome in Public Health Center Collaborate to Advance Research in Colon Cancer Screening
  • Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test
  • FDA Grants Breakthrough Designation to the Prescient Metabiomics LifeKit® Prevent Test for the Early Detection of Colon Polyps and Colon Cancer

Navigation

  • Home
  • LifeKit® Prevent
  • Technology
    • Microbiome Health
    • Microbiome Research News
    • Publications
  • About Us
    • Press Releases
    • Management
    • Careers
  • Contact Us
  • Facebook
  • X
  • RSS

Designed by Elegant Themes | Powered by WordPress